Everest Organics gets USFDA approval for Aroor manufacturing facility

06 Jun 2017 Evaluate

The United States Food and Drug Administration (USFDA) inspected Everest Organics’ Manufacturing Facility at Aroor Village and for the same the company has received the final approval. The USFDA has inspected the same from February 27, 2017 to March 3, 2017.

Everest Organics is engaged in the business of bulk drugs and active pharmaceutical ingredients (APIs). It is involved in manufacturing of bulk drugs, such as Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen and Benzimadizole.

Everest Organics Share Price

458.25 -17.75 (-3.73%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×